Search Results - "Aglitti, Andrea"

Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease by Persico, Marcello, Loguercio, Carmelina, Aglitti, Andrea, Gravina, Antonietta Gerarda, Dallio, Marcello, Rosato, Valerio, Masarone, Mario, Federico, Alessandro

“…Liver steatosis without alcohol consumption, namely, nonalcoholic fatty liver disease (NAFLD), is a common hepatic condition that encompasses a wide spectrum…”
Get full text

NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome by Rosato, Valerio, Masarone, Mario, Dallio, Marcello, Federico, Alessandro, Aglitti, Andrea, Persico, Marcello

“…Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and its incidence is definitely increasing. NAFLD is a…”
Get full text

Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis by Masarone, Mario, Troisi, Jacopo, Aglitti, Andrea, Torre, Pietro, Colucci, Angelo, Dallio, Marcello, Federico, Alessandro, Balsano, Clara, Persico, Marcello

“…Introduction Non-Alcoholic Fatty Liver Disease encompasses a spectrum of diseases ranging from simple steatosis to steatohepatitis (or NASH), up to cirrhosis…”
Get full text

The diagnostic conundrum in non-alcoholic fatty liver disease by Rosato, Valerio, Masarone, Mario, Aglitti, Andrea, Persico, Marcello

“…Non-alcoholic fatty liver disease (NAFLD) has become the most common liver alteration worldwide. It encompasses a spectrum of disorders that range from simple…”
Get full text

Characterisation of asymptomatic patients and efficacy of preventive measures for SARS-CoV-2 infection in a large population of Southern Italy: a cohort study by Masarone, Mario, Vaccaro, Emilia, Sciorio, Roberta, Torre, Pietro, Della Vecchia, Antonio, Aglitti, Andrea, Caliulo, Rita, Borrelli, Anna, Persico, Marcello

“…BackgroundThe SARS-CoV-2 pandemic has infected millions of people and has caused more than 2.30 million deaths worldwide to date. Several doubts arise about…”
Get full text

Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage by Masarone, Mario, Rosato, Valerio, Aglitti, Andrea, Bucci, Tommaso, Caruso, Rosa, Salvatore, Teresa, Sasso, Ferdinando Carlo, Tripodi, Marie Francoise, Persico, Marcello

“…Recent studies report a prevalence of non-alcoholic fatty liver disease (NAFLD) of between 70% and 80% in patients with metabolic syndrome (MS) and type 2…”
Get full text

Viral hepatitis: Milestones, unresolved issues, and future goals by Torre, Pietro, Aglitti, Andrea, Masarone, Mario, Persico, Marcello

“…In this review the current overall knowledge on hepatitis A, B, C, D, and E will be discussed. These diseases are all characterized by liver inflammation but…”
Get full text

Olmesartan-induced enteropathy: More than one entity? by Famularo, Giuseppe, Aglitti, Andrea, Magrini, Laura

Get full text

Efficacy and safety of new direct antiviral agents in hepatitis C virus–infected patients with diffuse large B‐cell non‐Hodgkin's lymphoma by Persico, Marcello, Aglitti, Andrea, Caruso, Rosa, De Renzo, Amalia, Selleri, Carmine, Califano, Catello, Abenavoli, Ludovico, Federico, Alessandro, Masarone, Mario

“…The association of hepatitis C virus (HCV) with non‐Hodgkin's lymphoma (NHL) has been demonstrated throughout the world. The new interferon‐free direct…”
Get full text

Hepatitis C virus infection in jail: Difficult-to-reach, not to-treat. Results of a point-of-care screening and treatment program by Masarone, Mario, Caruso, Rosa, Aglitti, Andrea, Izzo, Carmine, De Matteis, Giuseppe, Attianese, Maria Rosaria, Pagano, Antonio Maria, Persico, Marcello

“…An unmet objective in the pursuit of HCV elimination is the creation of a simple and fast operating model to identify difficult-to-treat populations, like…”
Get full text

FRI-326-Preclinical evaluation of endothelial dysfunction by peripheral artery tonometry and its correlations with untargeted metabolomic profiles by Masarone, Mario, Troisi, Jacopo, Calvanese, Gemma, Caruso, Rosa, Colucci, Angelo, Rosato, Valerio, Aglitti, Andrea, persico, marcello

Get full text

Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals by Lleo, Ana, Aglitti, Andrea, Aghemo, Alessio, Maisonneuve, Patrick, Bruno, Savino, Persico, Marcello, Rendina, Maria, Ciancio, Alessia, Lampertico, Pietro, Brunetto, Maurizia R., Di Marco, Vito, Zuin, Massimo, Andreone, Pietro, Villa, Erica, Troshina, Giulia, Degasperi, Elisabetta, Coco, Barbara, Calvaruso, Vincenza, Giorgini, Alessia M., Conti, Fabio, Di Leo, Alfredo, Marzi, Luca, Boccaccio, Vincenzo, Bollani, Simona, Colombo, Massimo

“…Despite the dramatic improvement in viral eradication rates that has been reached with direct antiviral agents (DAAs), the real benefit of viral eradication…”
Get full text

HCV point‐of‐care screening programme and treatment options for people who use drugs in a metropolitan area of Southern Italy by Persico, Marcello, Masarone, Mario, Aglitti, Andrea, Armenante, Ciro, Giordano, Aniello, Guardiola, Angela, Raimondi, Gabriella, Contaldi, Carlo, Nigro, Carmine, Marena, Giustina, De Luna, Antonio

“…Background and aims People who use drugs (PWUD) represent an active reservoir of HCV infection. The prevalence of chronic HCV infection in PWUD in Italy…”
Get full text

Vascular Endothelial Dysfunction in Inflammatory Bowel Diseases: Pharmacological and Nonpharmacological Targets by Federico, Alessandro, Persico, Marcello, Aglitti, Andrea, Rosato, Valerio, Masarone, Mario, Dallio, Marcello, Gravina, Antonietta Gerarda, Loguercio, Carmelina

“…Inflammatory bowel diseases, including Crohn’s disease and ulcerative colitis, are chronic inflammatory conditions involving primarily the gastrointestinal…”
Get full text

Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infection by Lawitz, Eric, Flisiak, Robert, Abunimeh, Manal, Sise, Meghan E., Park, Jun Y., Kaskas, Marwan, Bruchfeld, Annette, Wörns, Marcus‐Alexander, Aglitti, Andrea, Zamor, Philippe J., Xue, Zhenyi, Schnell, Gretja, Jalundhwala, Yash J., Porcalla, Ariel, Mensa, Federico J., Persico, Marcello

“…Background and Aims Chronic hepatitis C virus (HCV) infection increases the risk of incident chronic kidney disease (CKD) and progression to end‐stage renal…”
Get full text

THU-168-Real-life effectivness and safety of glecaprevir/pibrentasvir in HCV infected patients with chronic kidney disease by Persico, Marcello, Aglitti, Andrea, Caruso, Rosa, Calvanese, Gemma, Siervi, Pasqualina Di, Grazia, Nuzzo Maria, Tripodi, Marie Francoise, Masarone, Mario

Get full text

Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study by Persico, Marcello, Aglitti, Andrea, Milella, Michele, Coppola, Carmine, Messina, Vincenzo, Claar, Ernesto, Gentile, Ivan, Sogari, Fernando, Pierri, Paola, Surace, Lorenzo A., Morisco, Filomena, Tundo, Paolo, Brancaccio, Giuseppina, Serviddio, Gaetano, Gatti, Pietro, Termite, Antonio P., Di Costanzo, Giovan G., Caroleo, Benedetto, Cozzolongo, Raffaele, Coppola, Nicola, Longo, Annamaria, Fontanella, Luca, Federico, Alessandro, Rosato, Valerio, Terrenato, Irene, Masarone, Mario

“…Background and aims It is paramount to identify predictors of treatment failure with direct antiviral agents in ‘field‐practice’ patients, including people who…”
Get full text

Natremia and liver transplantation: The right amount of salt for a good recipe by Lenci, Ilaria, Milana, Martina, Grassi, Giuseppe, Signorello, Alessandro, Aglitti, Andrea, Baiocchi, Leonardo

“…An adequate balance between electrolytes and clear water is of paramount importance to maintaining physiologic homeostasis. Natremia imbalance and, in…”
Get full text

Corrigendum to “Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease” by Masarone, Mario, Rosato, Valerio, Dallio, Marcello, Gravina, Antonietta Gerarda, Aglitti, Andrea, Loguercio, Carmelina, Federico, Alessandro, Persico, Marcello

Get full text

Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice by Giannini, Edoardo G, Aglitti, Andrea, Borzio, Mauro, Gambato, Martina, Guarino, Maria, Iavarone, Massimo, Lai, Quirino, Levi Sandri, Giovanni Battista, Melandro, Fabio, Morisco, Filomena, Ponziani, Francesca Romana, Rendina, Maria, Russo, Francesco Paolo, Sacco, Rodolfo, Viganò, Mauro, Vitale, Alessandro, Trevisani, Franco

“…Despite progress in our understanding of the biology of hepatocellular carcinoma (HCC), this tumour remains difficult-to-cure for several reasons, starting…”
Get full text